trending Market Intelligence /marketintelligence/en/news-insights/trending/aDHdeSUNtJeZog3juJd9Tg2 content esgSubNav
In This List

CryoLife acquires surgical graft developer JOTEC

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


CryoLife acquires surgical graft developer JOTEC

CryoLife Inc. completed its previously announced acquisition of JOTEC AG.

In October, the company said it will acquire JOTEC for an up-front payment of $225 million.

JOTEC is a developer of technologically differentiated endovascular stent grafts and cardiac and vascular surgical grafts, focused on heart repair.